Search Articles
Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.
Quintessence division to develop drug tests with NIH grant
January 21, 2006
Madison, Wis. — QBI Life Sciences said it has received $175,000 from the National Institutes of Health and formed partnerships with UW-Madison and the University of Helsinki, Finland, to develop new drug tests.
QBI, a division of Quintessence Biosciences Inc. in Madison, will be working a way to find early indicators of potentially harmful interactions between different drugs given to the same person.
The grant comes under the NIH's Roadmap for Medical Research program. Keck UWCCC Small Molecule Screening Center at UW-Madison and the Drug Discovery and Development Technology Center in Helsinki will be working with QBI on the project.
"Achievement of the aims under this grant will lead to assays that quickly identify safety issues of drugs long before their use in people," said professor F. Michael Hoffman at UW-Madison, in a press release.
QBI, a division of Quintessence Biosciences Inc. in Madison, will be working a way to find early indicators of potentially harmful interactions between different drugs given to the same person.
The grant comes under the NIH's Roadmap for Medical Research program. Keck UWCCC Small Molecule Screening Center at UW-Madison and the Drug Discovery and Development Technology Center in Helsinki will be working with QBI on the project.
"Achievement of the aims under this grant will lead to assays that quickly identify safety issues of drugs long before their use in people," said professor F. Michael Hoffman at UW-Madison, in a press release.
Add Your Comment
Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and not immediately posted. Your email address will not be posted.
WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.
Advertisement
Most Popular Stories
Advertisement
Featured EventsMore…
- Apr 14 BioForward Professional Development Series - Managing Performance
- Apr 21 BioForward Professional Development Series - Project Management Essentials
- Apr 21 5th Annual Wisconsin Stem Cell Symposium -- The Road to Stem Cell Applications: Bioprocessing, Safety and Preclinical Evaluation
- Apr 22 - 23 9th Annual International Bioethics Forum - Taking the Measure of the Magic Mirror: Toward a Science of Consciousness
- Apr 22 UW-Madison IT Business Alignment Course
- May 19 - 20 Digital Healthcare Conference
- Oct 4 - 6 2010 World Stem Cell Summit
More Stories
- Measure would force White House, private sector to collaborate in cyber-crisis
- Adding it up: The politics of job creation mathematics in Wisconsin
- Google's biggest blunder
- HHS announces $162 million in 16 state HIE grants
- Farmville: The best and worst of Facebook
- Fending off digital decay, bit by bit
- What's the best way to support startups, services or cash?
- Technology transfers involving non-profit organizations: Special tax considerations
- Tearing down walls to meld IT and business
- Down To business: Electronic healthcare won't be denied
WTN Media Presents
